B-cell activation by crosslinking of surface IgM or ligation of CD40 involves alternative signal pathways and results in different B-cell phenotypes. - Wikidata - wikimedia - TriplyDB

B-cell activation by crosslinking of surface IgM or ligation of CD40 involves alternative signal pathways and results in different B-cell phenotypes.

B-cell activation by crosslinking of surface IgM or ligation of CD40 involves alternative signal pathways and results in different B-cell phenotypes.

http://www.wikidata.org/entity/Q34436036

about

Regulation of nuclear localization and transcriptional activity of TFII-I by Bruton's tyrosine kinase Ageing, autoimmunity and arthritis: senescence of the B cell compartment - implications for humoral immunity The cAMP Pathway as Therapeutic Target in Autoimmune and Inflammatory Diseases Immunological aspects in chronic lymphocytic leukemia (CLL) development beta1 integrin expression increases susceptibility of memory B cells to Epstein-Barr virus infection.Biphenotypic B/macrophage cells express COX-1 and up-regulate COX-2 expression and prostaglandin E(2) production in response to pro-inflammatory signals.Emergence of anthrax edema toxin as a master manipulator of macrophage and B cell functions Interleukin-12 and -10 and gamma interferon regulate polyclonal and ligand-specific expansion of murine B-1 cells.Positive selection of natural poly-reactive B cells in the periphery occurs independent of heavy chain allelic inclusion Splenic marginal zone lymphomas of mice.B cells and T cells are critical for the preservation of bone homeostasis and attainment of peak bone mass in vivo Microbiota regulate the ability of lung dendritic cells to induce IgA class-switch recombination and generate protective gastrointestinal immune responses.Bruton's tyrosine kinase links the B cell receptor to nuclear factor kappaB activation A differentiation pathway for B1 cells in adult bone marrow.Autoreactive thymic B cells are efficient antigen-presenting cells of cognate self-antigens for T cell negative selection.An essential role for Bruton's [corrected] tyrosine kinase in the regulation of B-cell apoptosis.A conserved enhancer element differentially regulates developmental expression of CD5 in B and T cells.Early generated B1 B cells with restricted BCRs become chronic lymphocytic leukemia with continued c-Myc and low Bmf expression.Dynamic variation of CD5 surface expression levels within individual chronic lymphocytic leukemia clones.The role of notch signaling in the development of a normal B-cell repertoire.The development and function of thymic B cells.B cells generated by B-1 development can progress to chronic lymphocytic leukemia.Lymphocytes and macrophages in adipose tissue in obesity: markers or makers of subclinical inflammation?Molecular single-cell analysis reveals that CD5-positive peripheral blood B cells in healthy humans are characterized by rearranged Vkappa genes lacking somatic mutation.A T cell controlled molecular pathway regulating the IgH locus: CD40-mediated activation of the IgH 3' enhancer.VHDJH gene sequences and antigen reactivity of monoclonal antibodies produced by human B-1 cells: evidence for somatic selection.VH gene expression in CD5 positive and CD5 negative B cell chronic lymphoid malignancies.Nucleosome-driven autoimmune response in lupus. Pathogenic T helper cell epitopes and costimulatory signals.B cell development in mice.Bi-ligand surfaces with oriented and patterned protein for real-time tracking of cell migration Understanding thymus-independent antigen-induced reduction of thymus-dependent immune responses.Deoxyspergualin preferentially inhibits the growth and maturation of anti-CD40-activated surface IgD+ B lymphocytes.CD6 Receptor Regulates Intestinal Ischemia/Reperfusion-induced Injury by Modulating Natural IgM-producing B1a Cell Self-renewal.[Thymic B cells: not simple bystanders of T cell lymphopoiesis].Macrophage regulation of B cell proliferation.NF-κB2/p100 deficiency impairs immune responses to T-cell-independent type 2 antigens.

P2860

Q24554472-2FEA87C9-3A7F-49D4-B8B2-49DC3A39C9E9 Q24805316-2C3826C9-DBA7-482E-A908-C0A20E815C8A Q26750377-2DF2C4DE-34C8-4CA9-B72F-416724E8D573 Q26865940-E8182E1C-BE49-4C5E-AA4A-13E601B888D6 Q33990687-4670ADFD-3005-421B-B38F-3D3F194C802C Q34505735-2CCDEBBE-A53D-45E5-9C4A-668D2F815259 Q35155908-CF8BC5A1-85F5-4588-898B-9560037DC203 Q35528365-6BBF1EEB-63D3-4027-9E86-BCC2AA0919E4 Q35636916-CF9197AD-D5F9-4AFD-97FD-2F505C54204A Q35786204-A59225C0-99E0-41EA-804B-FAFDA16DC6F9 Q35804512-EB32D0F7-6394-46EF-A9F9-A5A397A986D0 Q35880265-DE87B34E-129B-411C-BF86-00EC253AD6DC Q36368467-DE3B2616-C763-48E1-911A-1FCDB9B1097D Q37153619-8DF77586-DEFC-4955-AE76-28846F5C97C0 Q37240479-CE578887-F463-43DD-870A-A3B3C915A37F Q37305443-FB965F0F-F3F1-4B37-BFB1-9CC3B8868385 Q37374073-520D504D-D2BB-4CDA-94CB-24691A65B5E4 Q37500340-C372EB92-BAC2-4CFA-8133-0CF2651D5B93 Q37603583-D71B6CF7-94CC-4067-8AEF-4A3D146207C6 Q37608930-B0E592D0-F99C-490A-A5E4-45569FC76BFA Q38403129-80D08A3D-DB77-4742-AEB1-B6A7DF9266A0 Q38439338-4F242731-AD88-43E2-990A-882B0C8718D0 Q38985223-5929E3BB-2980-474D-8087-60091FD2AD67 Q39791417-73E65EF4-7319-4562-93B8-34F564A61B5E Q41078837-DB0983A1-9909-4BF1-9F2F-5FE8582B613E Q41125864-9FBF5B52-FB32-43D1-AA15-19E0F5D7C3BE Q41404449-57D4DE77-B572-41A3-96D8-DC60C4C26AB6 Q41500830-1C37A6A2-CDA2-459D-B4E5-39F1159CA9B8 Q41531174-65CDBCF8-4065-4D0F-8574-93EA445BA4FC Q42535595-F3B8347E-8D04-43B7-A379-DCA9062AF6F5 Q44935596-D00B4FB2-7909-4535-9B63-782C44A17AFC Q47901403-0794236B-66A0-4A37-B4E6-5E42A8C1DFCF Q48023143-0AA0547F-BD33-4EE1-878F-0B764A78AE68 Q49845683-7C65A1FC-44A9-4E15-96BE-EB48146AE50F Q51122070-F995044E-FD59-4B1B-866D-B752EB681595 Q54586665-DAD75B3F-B742-4CC9-90F5-59180C19158E

P2860

B-cell activation by crosslinking of surface IgM or ligation of CD40 involves alternative signal pathways and results in different B-cell phenotypes.

http://www.wikidata.org/entity/Q34436036

description

1995 nî lūn-bûn

@nan

1995 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

1995 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

1995年の論文

@ja

1995年論文

@yue

1995年論文

@zh-hant

1995年論文

@zh-hk

1995年論文

@zh-mo

1995年論文

@zh-tw

1995年论文

@wuu

name

B-cell activation by crosslink ...... n different B-cell phenotypes.

@ast

B-cell activation by crosslink ...... n different B-cell phenotypes.

@en

B-cell activation by crosslink ...... n different B-cell phenotypes.

@nl

type

label

B-cell activation by crosslink ...... n different B-cell phenotypes.

@ast

B-cell activation by crosslink ...... n different B-cell phenotypes.

@en

B-cell activation by crosslink ...... n different B-cell phenotypes.

@nl

prefLabel

B-cell activation by crosslink ...... n different B-cell phenotypes.

@ast

B-cell activation by crosslink ...... n different B-cell phenotypes.

@en

B-cell activation by crosslink ...... n different B-cell phenotypes.

@nl

P1433

Q34436036-5E9FA2EC-4D7A-454B-9544-FA07E451383D

P1476

Q34436036-E8983D35-8DD5-4016-B7C8-311E67766ABE

P2093

Q34436036-01C4552E-7DB3-443B-AAD2-19E76BEB5605

Q34436036-413C5241-4C42-4E9F-9EBE-62698728BC74

Q34436036-4D4600F2-E8F5-49F8-AE47-7CCF0663BEEE

Q34436036-895E16DA-67ED-4D51-B3DE-1BE4D9E8FAD9

Q34436036-91C2B1E8-A286-420F-9CA4-F2AE33F2E7F2

P2860

Q34436036-04C3F8B9-A6CF-4C8C-9030-798D5CDACD0D

Q34436036-0AF49C5C-C631-462C-9102-2E8D0C3226CC

Q34436036-0EFB7EFE-5B18-4B30-8F24-23CA6D50E254

Q34436036-140587C4-7A56-497A-9EB3-9E0887CDE1F6

Q34436036-16606A41-477E-4A1C-B2C4-2D6A8E7DB47B

Q34436036-24898B04-EF6C-4F2C-989E-7FF760636A4E

Q34436036-45E712EF-3422-4EF0-91C2-448EFBC8C2DC

Q34436036-4CD26B4B-3DB7-4449-B24B-9B4BD4DF9FC6

Q34436036-50382325-5F17-4D95-83CB-93991120AD5D

Q34436036-52DB6151-4D40-428D-9437-61626E1A2182

P304

Q34436036-D9F917A4-A6A9-475C-BB61-925E1790C0E8

P31

Q34436036-FB8EFE09-1023-42F1-80D8-15850CE4263C

P356

Q34436036-540D5F06-EA5D-4248-B5E9-6AB37BAE323F

P407

Q34436036-90706AD1-A6BA-43A0-BF6A-734449B44180

P433

Q34436036-87F46224-96D3-48C2-BD09-381D25154264

P478

Q34436036-AD93213E-09B2-4083-84C0-851341B4F7E2

P577

Q34436036-0D515F12-0DAC-441C-B991-7BE7A7C84068

P5875

Q34436036-CF689FAF-11DE-4892-B8DF-B44EFC1FD05E

P698

Q34436036-415FF4C3-E476-413A-9006-C996D795DD34

P932

Q34436036-B8CCB205-184B-47E4-8135-A7CDE073A541

P356

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

B-cell activation by crosslink ...... n different B-cell phenotypes.

@en

P2093

D C Parker

http://www.w3.org/2001/XMLSchema#string

H H Wortis

http://www.w3.org/2001/XMLSchema#string

J Zheng

http://www.w3.org/2001/XMLSchema#string

M Higer

http://www.w3.org/2001/XMLSchema#string

M Teutsch

http://www.w3.org/2001/XMLSchema#string

P2860

Molecular and biological characterization of a murine ligand for CD40

The T-cell transcription factor NFATp is a substrate for calcineurin and interacts with Fos and Jun

Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes

CD5 is associated with the human B cell antigen receptor complex

Molecular associations between the T-lymphocyte antigen receptor complex and the surface antigens CD2, CD4, or CD8 and CD5

Identification of calcineurin as a key signalling enzyme in T-lymphocyte activation

The mechanism of action of cyclosporin A and FK506

T-independent and T-dependent B lymphoblasts: helper T cells prime for interleukin 2-induced growth and secretion of immunoglobulins that utilize downstream heavy chains.

Cyclosporin A, FK-506, and rapamycin: pharmacologic probes of lymphocyte signal transduction.

The immunosuppressive and toxic effects of FK-506 are mechanistically related: pharmacology of a novel antagonist of FK-506 and rapamycin.

P304

3348-3352

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.92.8.3348

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

92

http://www.w3.org/2001/XMLSchema#string

P577

1995-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

15662043

http://www.w3.org/2001/XMLSchema#string

P698

7536930

http://www.w3.org/2001/XMLSchema#string

P932

42163

http://www.w3.org/2001/XMLSchema#string